PVLA: Pieris Pharmaceuticals Inc Sotuvga nisbatan narx
Pieris Pharmaceuticals (PVLA) kompaniyasining barqarorligi uning ishlanmalar portfelini optimallashtirish va strategik hamkorlardan tushadigan to'lovlarga asoslangan. P/S trayektoriyasi aktivlarning bozor qiymatini tasdiqlaydi, bunda ko'rsatkich qiymati 821.20 ga yetadi. Biznesning moslashuvchanligi sinovlar va ishlab chiqarishni tashqi pudratchilarga outsorsing qilish orqali ta'minlanadi, R&D ning yuqori samaradorligi esa laboratoriya uskunalarining a'lo holati va asbob-uskunalarning muntazam texnik xizmat ko'rsatilishi bilan qo'llab-quvvatlanadi.
Pieris Pharmaceuticals Inc (PVLA) kompaniyasi koʻrsatkichlari kesimi va tahlili
- aksiya narxi va konsensus maqsadli narx:
- bozor kapitallashuvi haqida ma'lumot:
- aksiyadorlik kapitalining balans qiymati ma'lumotlari:
- emitentning kredit yuki va likvidlik ko'rsatkichlari:
Qarzning kapitalga nisbati Pieris Pharmaceuticals|PVLA - Uzoq muddatli qarzning o'z kapitaliga nisbati|Qisqa muddatli qarzdorlikning kapitalga nisbati Pieris Corp|PVLA - Kompaniyaning jamlangan qarzlari|Sof aktivlarga qarzlar Pieris Pharmaceuticals Inc|PVLA - Kompaniyaning uzoq muddatli qarzi|Qisqa muddatli qarz hajmi Pieris Pharmaceuticals|Oraliq qoplash koeffitsiyenti pieris.com
- foyda va baholash multiplikatorlari ko'rsatkichlari:
PVLA - Kompaniyaning sof foydasi|Forvard foyda Pieris Pharmaceuticals|PVLA - P/E multiplikatori|Kelajakdagi narx-foyda multiplikatori Pieris Pharma|PVLA - PEG multiplikatori|EV/EBITDA multiplikatori Pieris Pharmaceuticals Inc|PVLA - Foizlar, soliqlar va eskirish to'lanishidan oldingi foyda|Sirpanuvchi yil uchun bir aksiya uchun foyda Pieris Pharmaceuticals|PVLA - So'nggi o'n ikki oy davomida bir aksiya uchun foyda|So'nggi 12 oy davomida bir aksiya uchun sof foydaning yillik o'sishi pieris.com|PVLA - Joriy yilda foyda o'sishi|Keyingi yil uchun foyda o'sishi prognozi Pieris Pharmaceuticals
- emitentning tushumi va sotuvlari tafsilotlari:
Kompaniyaning umumiy tahlili:PVLA, pieris.com
P/S koeffitsienti biznesning bozor qiymatini uning yillik daromadiga solishtiradi, bu esa daromadning har bir birligi uchun to'langan premiumni baholash va fundamental nomutanosibliklarni aniqlash imkonini beradi. Kapitalizatsiyaning daromadga nisbatini tahlil qilish orqali investor joriy darajalar stagnatsiya davrini aks ettirayotganini ko'radi, chunki bozor avvalgi hamkorlikdagi muvaffaqiyatsizliklarni allaqachon narxga kiritgan, Pieris Pharmaceuticals (PVLA) uchun yangi klinik pipeline drayverlari esa hali baholashga ta'sir ko'rsata boshlamagan.
Pieris Pharmaceuticals raqobatchilari
argenx.com - Kapitalizatsiya va daromad nisbati|P/S multiplikatori BNTX (BioNTech)|Abivax Pharma (ABVX) - Sotuvga nisbatan narx|ADMA - Narxning daromadga nisbati|Narxning sotuvga nisbati PTGX|IMVT: P/S multiplikatori|KNSA - Narx/daromad koeffitsiyenti|GRFS (Grifols) - P/S multiplikatori|Sotuvga nisbatan narx Adaptive Biotech ADPT|Narxning daromadga nisbati Celldex (CLDX)|AUPH (Aurinia Corp) - Bozor kapitallashuvining daromadga nisbati|P/S multiplikatori BCRX (BioCryst)|Narx/daromad koeffitsiyenti veratx.com (VERA)|DNTH - Narxning daromadga nisbati|Narx/daromad koeffitsiyenti Pharvaris NV PHVS|ABCL (AbCellera Biologics Inc) - Kapitalizatsiyaning daromadga nisbati|Tourmaline - Bozor kapitallashuvining daromadga nisbati|Narxning daromadga nisbati Precigen, Inc.|pharming.com - Narxning sotuvga nisbati|P/S multiplikatori NKTR|UPB (Upstream Bio, Inc.) - Bozor kapitallashuvining daromadga nisbati|P/S multiplikatori ZBIO (Zenas Biopharma, Inc.)|P/S multiplikatori Immunome Bio IMNM|GOSS - Narxning daromadga nisbati|Bozor kapitallashuvining daromadga nisbati KALV (kalvista.com)|Septerna (SEPN) - Narxning daromadga nisbati|Kapitalizatsiyaning daromadga nisbati Savara Inc|RIGL (Rigel Pharmaceuticals Inc) - P/S multiplikatori|P/S multiplikatori AnaptysBio Inc.|P/S multiplikatori ATXS|Kapitalizatsiyaning daromadga nisbati engene.com ENGN|P/S multiplikatori RAPT (RAPT Therapeutics)|Aerovate Therapeutics, Inc. (JBIO) - Sotuvga nisbatan narx|ACRS: Kapitalizatsiyaning daromadga nisbati|KYTX - P/S multiplikatori|TLSA (Tiziana Life Sciences) - Kapitalizatsiyaning daromadga nisbati|CABA: Kapitalizatsiyaning sotish hajmiga nisbati|VTYX (Ventyx Biosciences, Inc.) - P/S multiplikatori|Theratechnologies, Inc. (THTX) - Narx/daromad koeffitsiyenti|P/S multiplikatori AVTX|Kapitalizatsiyaning daromadga nisbati Eledon Pharmaceuticals, Inc ELDN|P/S multiplikatori AGEN (Agenus)|P/S multiplikatori climbbio.com CLYM|ZURA - Narxning daromadga nisbati|ATYR: Narxning daromadga nisbati|adagene.com (ADAG) - Narxning daromadga nisbati|IMA - Narx/daromad koeffitsiyenti|Narxning daromadga nisbati Shattuck Labs Inc|Equillium Bio - Narxning sotuvga nisbati|Kapitalizatsiyaning daromadga nisbati CNTB (Connect Biopharma)|Narxning daromadga nisbati IMUX (immunic-therapeutics.com)|Narxning daromadga nisbati Atara Bio ATRA|InflaRx NV - Narxning daromadga nisbati|X4 Pharmaceuticals - P/S multiplikatori|ACET - P/S multiplikatori|celularity.com (CELU) - Narxning daromadga nisbati|Narxning sotuvga nisbati INMB (INmune Bio Inc)|BRNS (Barinthus Bio) - P/S multiplikatori|KZR: Bozor kapitallashuvining daromadga nisbati|P/S multiplikatori SABS|P/S multiplikatori akaritx.com (AKTX)|Narxning daromadga nisbati Enlivex Therapeutics Ltd. ENLV|Bozor kapitallashuvining daromadga nisbati QTTB|GOVX - Narxning daromadga nisbati|Edesa Biotech Corp (EDSA) - Kapitalizatsiyaning daromadga nisbati|IBIO: P/S multiplikatori|Carisma Therapeutics Inc. (CARM) - P/S multiplikatori|Kapitalizatsiyaning daromadga nisbati XTLB|BOLT: Bozor kapitallashuvining daromadga nisbati|P/S multiplikatori HCWB|Narx/daromad koeffitsiyenti aptevotherapeutics.com|Narxning daromadga nisbati AIM ImmunoTech Inc. AIM|ADTX - Kapitalizatsiyaning daromadga nisbati|GRI - Narxning daromadga nisbati|XORTX Therapeutics Inc (XRTX) - Kapitalizatsiyaning daromadga nisbati|HIND (ReShape Lifesciences) - Kapitalizatsiyaning daromadga nisbati|Revelation Biosciences Corp (REVB) - P/S multiplikatori|Narxning daromadga nisbati Indaptus Therapeutics|Kapitalizatsiya va daromad nisbati SCNI (scinai.com)|P/S multiplikatori CALI|AFMD - Sotuvga nisbatan narx|Narxning daromadga nisbati Allakos ALLK|HOOK (HOOKIPA Pharma, Inc.) - Narxning sotuvga nisbati|IGM Bio - P/S multiplikatori|Narx/daromad koeffitsiyenti iteostherapeutics.com ITOS|OCEA: P/S multiplikatori|Sotuvga nisbatan narx TC BioPharm (Holdings) Plc (TCBP)|Narxning daromadga nisbati Third Harmonic Bio, Inc
